feed,title,long_url,short_url
Benzinga,These Analysts Revise Their Forecasts On EQT Following Merger News,https://benzinga.com/m-a/24/03/37630803/these-analysts-revise-their-forecasts-on-eqt-following-merger-news,https://da.gd/Qu1hp
Benzinga,What's In Store For Nike In Q3 Earnings? Analyst Sees Revenue Decline In North America & EMEA,https://benzinga.com/analyst-ratings/analyst-color/24/03/37630804/whats-in-store-for-nike-in-q3-earnings-analyst-sees-revenue-decline-in-north-americ,https://da.gd/LiRbD
Benzinga,"FDA Casts Doubts On Geron's Blood Cancer Drug, But Analyst Sees High Probability For Imetelstat's Potential Approval For MDS Anemia Treatment",https://benzinga.com/analyst-ratings/analyst-color/24/03/37630792/fda-casts-doubts-on-gerons-blood-cancer-drug-but-analyst-sees-high-probability-for-,https://da.gd/bfTvs
